Mission: The dignity of each human being mandates the effort of providing equal and adequate care to patients with life-threatening blood disorders, such as aplastic anemia, or liquid or solid cancer, regardless of their ethnicity or social status, and in any region of the world.
- To support hematology/oncology health providers in low income countries with technological and educational resources,
- To collaborate with hematology/oncology providers in low income or developing countries in establishing standard treatment guidelines and designing clinical studies that may address specific needs of local patients with severe blood disorders or malignancies,
- To promote the culture, develop policies and favor local and global networking focused on increasing equal access to care for patients of low income countries.
- Limited or lacking subspecialty (hem/onc) training in developing countries,
- Lack of infrastructure for controlled clinical trials, data collection and outcome analysis,
- Limitations in work environment (hospital facilities, transportation, rural vs urban care settings, etc.),
- Public vs private funded institutions with high degree of treatment disparities for low income patients,
- Cost of chemotherapy drugs not affordable for the majority of the World’s population,
- “Brain drain” of local providers trained abroad,
- Limited financial resources.
- To create an infrastructure where training programs can be developed by identifying and addressing specific needs in low income/developing countries. Training can be provided by means of rotations for UIC faculty and trainees abroad, telemedicine programs, and hosting providers from other countries at UIC as visiting observers.
- To obtain external research funding to support the growth of health care through collaborations aimed at analyzing and improving outcome results, addressing barriers to cancer screening and developing technology innovation in low income/developing countries.
- To create an External Consulting Board in Global Health for Hem/Onc through the collaboration of public or private educational institutions, government law/policy agencies, corporate financial subjects, philanthropic organizations and volunteers (foundations, NGOs). This board would contribute to the development of the global program through academic experts, innovative suggestions and specific projects.
- To develop philanthropic mechanisms that can sustain the activities of the program.
Damiano Rondelli, MD